Article PDF
Avoid common mistakes on your manuscript.
References
Wynendaele W, Derua R, Hoylaerts MF, et al. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo? Ann Oncol. 1999;10:965–71.
George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res. 2000;6:3147–152.
Pramanik R, Tyagi A, Agarwala S, Vishnubhatla S, Dhawan D, Bakhshi S. Evaluation of vascular endothelial growth factor (VEGF) and thrombospondin-1 as bio-markers of metronomic chemotherapy in progressive pediatric solid malignancies. Indian Pediatr. 2020; 57:508–11.
Vermeulen PB, Salven P, Benoy I, Gasparini G, Dirix LY. Blood platelets and serum VEGF in cancer patients. Br J Cancer. 1999;79:370–73.
Kesari S, Schiff D, Doherty L, et al. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro Oncol. 2007;9:354–63.
Kieran MW, Turner CD, Rubin JB, et al. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol. 2005;27;573–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pramanik, R., Bakhshi, S. Authors’ Reply. Indian Pediatr 57, 1188–1189 (2020). https://doi.org/10.1007/s13312-020-2082-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-2082-5